Xenon Pharmaceuticals Inc. (NASDAQ:XENE) appears in 239 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 329,333 | 6.90% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 1,343 | 0.02% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 5,448,888 | 100.91% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 1,154,922 | 31.99% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | -81,072 | -3.18% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 474,671 | 375.85% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 369,577 | 8.86% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | -1,779,953 | -49.37% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 2,000 | 1,000.00% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 140,149 | 3.55% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | -900,000 | -33.33% | $0.00 |
| Capital International Investors | 31 Dec, 2025 | 0 | 233,466 | 7.34% | $0.00 |
| Holocene Advisors, LP | 31 Dec, 2025 | 0 | -694,472 | -35.14% | $0.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 0 | -60,603 | -3.66% | $0.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 0 | -150,000 | -10.71% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | -1,304,034 | -46.60% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 26,083 | 1.78% | $0.00 |
| First Turn Management, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 362,115 | 37.76% | $0.00 |